Unintentional drug poisoning in the United States by National Center for Injury Prevention and Control (U.S.) & Centers for Disease Control and Prevention (U.S.)
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A poisoning occurs when a person's exposure to a natural or manmade substance has an 
undesirable effect. A drug poisoning occurs when that substance is an illegal, prescription, or 
over-the-counter drug. Most fatal poisonings in the United States result from drug poisoning.
Poisoning can be classified as:
• self-harm or suicide when the person wants to harm himself;
• assault or homicide when the person wants to harm another; and
• unintentional, also known as "accidental," when no harm is intended. Unintentional drug 
poisoning includes drug overdoses resulting from drug misuse, drug abuse, and taking too 
much of a drug for medical reasons.
This document summarizes the most recent information about deaths and emergency 
department (ED) visits resulting from drug poisoning. Information about deaths comes from 
death certificates for deaths in 2007. Information about emergency department visits comes 
from a national surveillance system, the Drug Abuse Warning Network (DAWN), operated by 
the Substance Abuse and Mental Health Services Administration (SAMHSA).
Drug overdose death rates in the United States have never been higher
• Drug overdose death rates have risen steadily in the United States since 1970.
(See Figure 1)
• In 2007, 27,658 unintentional drug 
overdose deaths occurred in the 
United States.
• Drug overdose deaths were 
second only to motor vehicle crash 
deaths among leading causes of 
unintentional injury death in 2007 in 
the United States.
Rates have increased roughly five-fold 
since 1990.
• Age-adjusted rates of drug overdose 
death for whites have exceeded 
those among African Americans 
since 2003.
Figure 1: Rate of unintentional drug overdose death in 
the United States, 1 970 -2007
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The increase in drug overdose death rates is largely because 
of prescription opioid painkillers
• Among deaths attributed to drugs, 
the most common drug categories 
are cocaine, heroin, and a type 
of prescription drug called opioid 
painkillers.
• "Opioids" are synthetic versions 
of opium. They have the ability to 
reduce pain but can also suppress 
breathing to a fatal degree when 
taken in excess. Examples of opioids 
are oxycodone (OxyContin®), 
hydrocodone (Vicodin®), and 
methadone.
• There has been at least a 10-fold 
increase in the medical use of opioid 
painkillers during the last 20 years 
because of a movement toward more 
aggressive management of pain.
• Because opioids cause euphoria, they 
have been associated increasingly 
with misuse and abuse. Opioids are 
now widely available in illicit markets 
in the United States.
Overall drug overdose death rates in the United States vary by state and region
• States in the Appalachian region and 
the Southwest have the highest death 
rates. (See Figure 3)
• The highest drug overdose death rate 
was found in West Virginia, which was 
nearly 7 times that of the state with 
the lowest drug overdose death rate,
South Dakota.
• In 2007, states such as California 
and New York had some of the lowest 
overall death rates among all states 
because of low opioid overdose rates.
In contrast, in the early 1990s these 
states had some of the highest overall 
rates, largely because of high heroin 
and cocaine overdose rates.
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In 2007, the number of deaths involving opioid 
analgesics was 1.93 times the number involving 
cocaine and 5.38 times the number involving heroin.
Figure 2: Unintentional drug overdose deaths by m ajor type  
of drug, United States, 1 9 99 -2007
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In 2007, opioids were involved in more overdose 
deaths than heroin and cocaine combined. 
(See Figure 2)
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Men and middle-aged people are more likely to die from drug overdose
• In 2007, 18,029 drug overdose deaths 
occurred among males and 9,626 among 
females. Male rates exceeded female 
rates in almost every age group. Men 
have historically had higher rates of 
substance abuse than women. (See 
Figure 4)
• Male rates have doubled and female 
rates have tripled since 1999.
• For both sexes, the highest rates were 
in the 45-54 years old age group. Rates 
declined dramatically after the age of 54.
• After age 64, the male and female rates 
become comparable, probably as a
result of the reduction in rates of substance abuse with age.
Among emergency department visits for the misuse or abuse of drugs, legal drugs 
have caught up with illegal drugs
• The Drug Abuse Warning Network 
(DAWN) estimates ED visits caused by 
illicit drugs or the nonmedical use of 
legal drugs, which includes taking more 
than the prescribed amount, taking 
drugs prescribed for someone else, or 
substance abuse. Nonmedical use by this 
definition does not include use of drugs 
to harm oneself, e.g., suicide attempts, 
or unintentional ingestions.
ED visits for the nonmedical use of 
prescription and over-the-counter drugs 
are now comparable to ED visits for use 
of illicit drugs like heroin and cocaine.
• In 2008, DAWN estimates show that prescription or over-the-counter drugs used 
nonmedically were involved in 1.0 million ED visits, and illicit drugs were involved in 1.0 
million visits (See Figure 5). Among the legal drugs, the most common drug categories 
involved were drugs acting on the central nervous system, especially opioid painkillers, and 
psychotherapeutic drugs, especially sedatives and antidepressants. Opioid painkillers were 
associated with approximately 306,000 visits and benzodiazepines (a type of sedative) with
272.000 visits.
• Among illicit drugs, cocaine was involved in 482,000 visits, and heroin was involved in
201.000 visits.
• People who abuse opioids have direct health care costs more than eight times those of 
nonabusers. A conservative estimate of the costs to society of prescription opioid abuse in the 
United States was $8.6 billion in 2001 ($9.5 billion in 2005 dollars).
Figure 5: Estimated num bers o f ED visits involving legal drugs 
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Figure 4: Unintentional drug overdose death rates 
by sex and age group, United States, 2007
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Recommendations
The following recommendations are not founded in evidence-based research bu t are based on promising 
interventions and expert opinion. Additional research is needed to understand the impact o f these 
interventions on decreasing unintentional drug poisoning and on health care costs. A ll o f the following 
recommendations should be implemented in concert and collaboration with public health entities and 
other relevant stakeholders.
Health Care Providers
• Use opioid medications for acute or chronic pain only after determining that alternative therapies do not 
deliver adequate pain relief. The lowest effective dose of opioids should be used.
• In addition to behavioral screening and use of patient contracts, consider random, periodic, targeted 
urine testing for opioids and other drugs for any patient less than 65 years old with noncancer pain 
who is being treated with opioids for more than six weeks.
• If a patient's dosage has increased to >120 morphine milligram equivalents per day without substantial 
improvement in pain and function, seek a consult from a pain specialist.
• Do not prescribe long-acting or controlled-release opioids (e.g., OxyContin®, fentanyl patches, and 
methadone) for acute pain.
• Periodically request a report from your state prescription drug monitoring program on the prescribing of 
opioids to your patients by other providers.
Private Insurance Providers and Pharmacy Benefit Managers (PBMs)
• Identify patients using opioids for noncancer pain who 1) receive a total of 120 or more morphine 
milligram equivalents of opioids per day from two or more sources; 2) show inappropriate patterns of 
usage such as multiple prescriptions for the same medication from different providers; or 3) also use a 
sedative-hypnotic. Notify the prescribing providers about such patients.
• For patients whose use of multiple providers cannot be justified on medical grounds, insurers and 
PBMs should only reimburse opioid prescription claims from a single designated physician and a single 
designated pharmacy.
State and Federal Agencies
• To the extent permitted by applicable law, state prescription drug monitoring programs should routinely 
send reports to providers on patients less than 65 years old if they are being treated with opioids for 
more than 6 weeks by two or more providers or if there are signs of inappropriate use of controlled 
substances. (If legal authority to do so does not exist, work toward obtaining that authority.)
• To the extent permitted by applicable law, state and federal benefits programs should consider 
monitoring prescription claims information for signs of inappropriate use of controlled substances by 
patients. For patients whose use of multiple providers cannot be justified on medical grounds, such 
programs should consider reimbursing opioid prescription claims from a single designated physician and 
a single designated pharmacy.
• State and federal agencies should work to improve the availability of substance abuse treatment 
services.
For More Information on Unintentional Drug Poisonings in the United States, go to:
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